Cargando…
Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169501/ https://www.ncbi.nlm.nih.gov/pubmed/37158935 http://dx.doi.org/10.1186/s13045-023-01449-x |
| _version_ | 1785039054501314560 |
|---|---|
| author | Elnaggar, Muhammad Agte, Sarita Restrepo, Paula Ram, Meghana Melnekoff, David Adamopoulos, Christos Stevens, Mark M. Kappes, Katerina Leshchenko, Violetta Verina, Daniel Jagannath, Sundar Poulikakos, Poulikos I. Parekh, Samir Laganà, Alessandro |
| author_facet | Elnaggar, Muhammad Agte, Sarita Restrepo, Paula Ram, Meghana Melnekoff, David Adamopoulos, Christos Stevens, Mark M. Kappes, Katerina Leshchenko, Violetta Verina, Daniel Jagannath, Sundar Poulikakos, Poulikos I. Parekh, Samir Laganà, Alessandro |
| author_sort | Elnaggar, Muhammad |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10169501 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101695012023-05-11 Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation Elnaggar, Muhammad Agte, Sarita Restrepo, Paula Ram, Meghana Melnekoff, David Adamopoulos, Christos Stevens, Mark M. Kappes, Katerina Leshchenko, Violetta Verina, Daniel Jagannath, Sundar Poulikakos, Poulikos I. Parekh, Samir Laganà, Alessandro J Hematol Oncol Correction BioMed Central 2023-05-08 /pmc/articles/PMC10169501/ /pubmed/37158935 http://dx.doi.org/10.1186/s13045-023-01449-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Elnaggar, Muhammad Agte, Sarita Restrepo, Paula Ram, Meghana Melnekoff, David Adamopoulos, Christos Stevens, Mark M. Kappes, Katerina Leshchenko, Violetta Verina, Daniel Jagannath, Sundar Poulikakos, Poulikos I. Parekh, Samir Laganà, Alessandro Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation |
| title | Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation |
| title_full | Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation |
| title_fullStr | Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation |
| title_full_unstemmed | Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation |
| title_short | Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation |
| title_sort | correction: triple mapk inhibition salvaged a relapsed post-bcma car-t cell therapy multiple myeloma patient with a braf v600e subclonal mutation |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169501/ https://www.ncbi.nlm.nih.gov/pubmed/37158935 http://dx.doi.org/10.1186/s13045-023-01449-x |
| work_keys_str_mv | AT elnaggarmuhammad correctiontriplemapkinhibitionsalvagedarelapsedpostbcmacartcelltherapymultiplemyelomapatientwithabrafv600esubclonalmutation AT agtesarita correctiontriplemapkinhibitionsalvagedarelapsedpostbcmacartcelltherapymultiplemyelomapatientwithabrafv600esubclonalmutation AT restrepopaula correctiontriplemapkinhibitionsalvagedarelapsedpostbcmacartcelltherapymultiplemyelomapatientwithabrafv600esubclonalmutation AT rammeghana correctiontriplemapkinhibitionsalvagedarelapsedpostbcmacartcelltherapymultiplemyelomapatientwithabrafv600esubclonalmutation AT melnekoffdavid correctiontriplemapkinhibitionsalvagedarelapsedpostbcmacartcelltherapymultiplemyelomapatientwithabrafv600esubclonalmutation AT adamopouloschristos correctiontriplemapkinhibitionsalvagedarelapsedpostbcmacartcelltherapymultiplemyelomapatientwithabrafv600esubclonalmutation AT stevensmarkm correctiontriplemapkinhibitionsalvagedarelapsedpostbcmacartcelltherapymultiplemyelomapatientwithabrafv600esubclonalmutation AT kappeskaterina correctiontriplemapkinhibitionsalvagedarelapsedpostbcmacartcelltherapymultiplemyelomapatientwithabrafv600esubclonalmutation AT leshchenkovioletta correctiontriplemapkinhibitionsalvagedarelapsedpostbcmacartcelltherapymultiplemyelomapatientwithabrafv600esubclonalmutation AT verinadaniel correctiontriplemapkinhibitionsalvagedarelapsedpostbcmacartcelltherapymultiplemyelomapatientwithabrafv600esubclonalmutation AT jagannathsundar correctiontriplemapkinhibitionsalvagedarelapsedpostbcmacartcelltherapymultiplemyelomapatientwithabrafv600esubclonalmutation AT poulikakospoulikosi correctiontriplemapkinhibitionsalvagedarelapsedpostbcmacartcelltherapymultiplemyelomapatientwithabrafv600esubclonalmutation AT parekhsamir correctiontriplemapkinhibitionsalvagedarelapsedpostbcmacartcelltherapymultiplemyelomapatientwithabrafv600esubclonalmutation AT laganaalessandro correctiontriplemapkinhibitionsalvagedarelapsedpostbcmacartcelltherapymultiplemyelomapatientwithabrafv600esubclonalmutation |